A Current Procedural Terminology (CPT) code assigned to laboratory analyses that examine deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) to identify variations associated with disease or health risks. For instance, a specific five-gene panel assessing breast cancer risk might have a corresponding CPT code distinct from a single-gene analysis for cystic fibrosis. The code facilitates standardized communication between healthcare providers, laboratories, and payers.
These standardized codes are crucial for accurate billing and reimbursement for these sophisticated analyses. Proper coding ensures that laboratories receive appropriate compensation for the resources and expertise involved in performing these tests. Moreover, the consistent use of these identifiers allows for tracking utilization trends, aiding in the development of informed healthcare policies, and supporting research initiatives aimed at understanding the clinical utility and economic impact of genomic medicine.